United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts $348.65 -1.54 (-0.44%) (As of 10/25/2024 08:57 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 30Before Market OpensConfirmedActual EPS (Jul. 31) $5.85 Missed By -$0.48 Consensus EPS (Jul. 31) $6.33 Conference Call TranscriptConference Call AudioEarnings Press ReleaseSEC 10-Q/10-K Filing Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueUTHR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UTHR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIHere’s how to start a “Weekend Side Hustle” from your sofaHere’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand. And that’s how you can kickstart your very own “Weekend Side Hustle!” Now that you know that…Let me show you how I target extra income as early as THIS weekend! United Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$5.10$5.93$5.52Q2 20243$5.55$6.50$5.92Q3 20243$5.69$7.41$6.33Q4 20242$5.40$7.83$6.62FY 202410$21.74$27.67$24.38Q1 20251$6.59$6.59$6.59Q2 20251$6.36$6.36$6.36Q3 20251$6.26$6.26$6.26Q4 20251$5.65$5.65$5.65FY 20254$24.86$24.86$24.86Q1 20261$6.42$6.42$6.42Q2 20261$6.62$6.62$6.62UTHR Earnings Date and InformationUnited Therapeutics last issued its quarterly earnings results on July 31st, 2024. The biotechnology company reported $5.85 earnings per share for the quarter, missing analysts' consensus estimates of $6.33 by $0.48. The business had revenue of $714.90 million for the quarter, compared to the consensus estimate of $691.87 million. Its quarterly revenue was up 19.8% compared to the same quarter last year. United Therapeutics has generated $21.15 earnings per share over the last year ($21.15 diluted earnings per share) and currently has a price-to-earnings ratio of 16.0. Earnings for United Therapeutics are expected to grow by 11.53% in the coming year, from $24.72 to $27.57 per share. United Therapeutics has confirmed that its next quarterly earnings report will be published on Wednesday, October 30th, 2024. United Therapeutics will be holding an earnings conference call on Wednesday, October 30th at 9:00 AM Eastern. Interested parties can register for or listen to the call.. Read More United Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/30/2024(Confirmed)------- 7/31/2024Q2 2024$6.33$5.85($0.48)$5.85$691.87 million$714.90 million 5/1/2024Q1 2024$5.63$6.17+$0.54$6.17$620.31 million$677.70 million 2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01 million$614.70 million 11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82 million$609.40 million 8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18 million$596.50 million 5/3/2023Q1 2023$4.26$4.86+$0.60$4.86$514.37 million$506.90 million Buy these “two-bagger” stocks (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today!2/22/2023Q4 2022$4.12$2.67($1.45)$2.67$519.20 million$491.50 million 11/2/2022Q3 2022$3.57$4.91+$1.34$4.91$492.92 million$516.00 million 8/3/2022Q2 2022$4.10$2.41($1.69)$2.41$461.06 million$466.90 million 5/4/2022Q1 2022$2.96$5.03+$2.07$5.03$420.02 million$461.90 million 2/24/2022Q4 2021$3.77$2.35($1.42)$2.35$427.59 million$415.20 million 11/3/2021Q3 2021$3.37$3.42+$0.05$3.42$421.45 million$444.70 million 8/4/2021Q2 2021$3.02$3.65+$0.63$3.65$378.54 million$446.50 million 5/5/2021Q1 2021$2.60$0.61($1.99)$0.61$368.31 million$379.10 million 2/23/2021Q4 2020$2.96$2.19($0.77)$2.19$362.04 million$384.90 million 10/28/2020Q3 2020$2.41$3.84+$1.43$3.84$357.95 million$380.10 million 7/29/2020Q2 2020$2.41$2.41-$2.41$339.97 million$362.00 million 4/29/2020Q1 2020$2.43$3.12+$0.69$3.12$343.68 million$356.30 million 2/26/2020Q4 2019$2.47$1.20($1.27)$1.20$357.14 million$311.10 million 10/30/2019Q3 2019$2.34$3.16+$0.82$3.01$342.28 million$401.50 million United Therapeutics Earnings - Frequently Asked Questions When is United Therapeutics's earnings date? United Therapeutics has confirmed that its next quarterly earnings data will be published on Wednesday, October 30th, 2024. Learn more on UTHR's earnings history. Did United Therapeutics beat their earnings estimates last quarter? In the previous quarter, United Therapeutics (NASDAQ:UTHR) missed the analysts' consensus estimate of $6.33 by $0.48 with a reported earnings per share (EPS) of $5.85. Learn more on analysts' earnings estimate vs. UTHR's actual earnings. How can I listen to United Therapeutics's earnings conference call? The conference call for United Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read United Therapeutics's conference call transcript? The conference call transcript for United Therapeutics's latest earnings report can be read online. Read Transcript How can I view United Therapeutics's earnings report? United Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.62 billion. How much profit does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded net income of $984.80 million. UTHR has generated $21.15 earnings per share over the last four quarters. What is United Therapeutics's price-to-earnings ratio? United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 16.02 and a forward price-to-earnings ratio of 14.10. The price/earnings-to-growth ratio is 1.35. What is United Therapeutics's EPS forecast for next year? United Therapeutics's earnings are expected to grow from $24.72 per share to $27.57 per share in the next year, which is a 11.53% increase. ` More Earnings Resources from MarketBeat Related Companies TEVA Earnings Results BPMC Earnings Results BHVN Earnings Results BBIO Earnings Results PRGO Earnings Results BHC Earnings Results ARWR Earnings Results ALNY Earnings Results BIIB Earnings Results BMRN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat This page (NASDAQ:UTHR) was last updated on 10/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredCountdown to Chaos begins WednesdayWill it be Trump or Harris? In an exclusive interview on Wednesday, October 30, at 8 p.m. ET, he’ll explain...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)27 of the world's brightest minds in crypto are gathering to reveal their top picks and predictions for the ma...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTiny Defense Firm Set for Huge Gains with New US ContractOne tiny defense firm just won a groundbreaking US military contract… That could hand early investors gains...Behind the Markets | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding United Therapeutics Co. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
